logo
Top Stories
56
45
Dassault-Safran-121317-lg.jpg

French aircraft maker Dassault Aviation SA said Wednesday that following repeated delays, it has terminated a contract with French defense company Safran for its Silvercrest engine that was intended to power Dassault's Falcon 5X business jet.

MarioDraghi-121417-lg.jpg

The European Central Bank raised the euro area growth forecasts, as it gained confidence from the strong momentum this year, but inflation was seen to remain short of its target into 2020, which Mario Draghi called a "muted" news that warrants support...

DanJohnson-121417-lg.jpg

A Kentucky lawmaker has apparently took his own life just two days after facing allegation that he sexually assaulted a minor. Danny Ray Johnson, a Republican state representative of Kentucky, died of self-inflicted gunshot wound on Wednesday evening....

wallstreet3-121214_14Dec17-lg.jpg

After an early move to the upside, stocks turned lower over the course of the trading session on Thursday. The Dow pulled back into negative territory after reaching a new record intraday high.

Stock-Market-500_07Dec17.jpg Asian stocks were trading mostly higher for the second day running Friday even as underlying sentiment remained somewhat cautious ahead of Chinese trade data and U.S. jobs figures for November due later in the day. The yen weakened against the dollar...
FDA-Approval-Nov-120617.jpg The process of drug development is challenging. Some drugs pass the FDA muster easily, while some face a host of hurdles before getting the official stamp of approval. So far, 40 novel drugs have been approved for this year, compared to just 22 in 2016. Let's take a look at the drugs that crossed the regulatory finish line in November.
Adaptimmune-120817.jpg Adaptimmune Therapeutics PLC (ADAP) has returned 97% this year, while the iShares Nasdaq Biotechnology ETF index, which tracks the investment results of biotechnology and pharmaceutical equities listed on the NASDAQ, is up only 17% year-to-date.
China-Trade-120817.jpg China's exports expanded much faster than expected in November but the annual increase in imports outpaced export growth, data from the General Administration of Customs showed Friday. In dollar terms, exports advanced 12.3 percent year-over-year in November, well above the 5.9 percent rise economists had forecast.
More
President-Trump2-121117.jpg Responding to renewed allegations of sexual misconduct by President Donald Trump, the White House declared that the American people have voiced their opinion of the accusations by electing the real estate tycoon as their president. The statement by...
More
DevinNunes-120817.jpg A House Ethics Committee investigation has cleared House Intelligence Committee Chairman Devin Nunes, R-Calif., of accusations of disclosing classified information. The investigation had led Nunes to step aside from leading a probe into alleged Russian meddling in last year's elections.
More
BankofEngland-121417.jpgThe Bank of England policymakers unanimously decided to leave its key interest rate unchanged on Thursday after tightening it for the first time in a decade in November. The Monetary Policy Committee, headed by Governor Mark Carney, voted to maintain the benchmark rate at 0.50 percent.
More
The Swiss stock market ended Thursday's session with a small loss. The market rose above the 9,400 point level for the first time in two years this morning, but pulled back in the afternoon as shares of index heavyweight Nestlé weakened. Central banks were in focus Thursday, as investors had their...
CryptoCompany-121417.jpg
Crypto Co., engaged in the digital currencies and blockchain sector, announced its plans to execute a 10-for-1 stock split, citing the significant growth in the value and demand for its shares amid the ongoing digital currency market boost. CEO Mike Poutre said, ""We are aware of the recent fluctuation in our stock, and want to see orderly market activity surrounding the trading of our stock."
More
Today's Daily Dose brings you news about Aduro's revised pipeline; FDA approval of a new indication for CoolSculpting; Blueprint's stock offering; encouraging preliminary results from Cellectis' CALM and PALL trials; expanded FDA approval for GlaxoSmithKline's Nucala and Omeros' OMIDRIA. More
Here's what is making news at GHDX, ARGX and RMTI. More
Follow RTT
Economic Calendar
DateIndicatorPeriodCountry
12/14/17 18:50Tankan Large All Indust CapexQ4 Japan
12/14/17 18:50Tankan Large Mfrs IndexQ4 Japan
12/14/17 18:50Tankan Large Mfrs OutlookQ4 Japan
12/14/17 18:50Tankan Non-Mfrs IndexQ4 Japan
12/14/17 18:50Tankan Non-Mfrs OutlookQ4 Japan
12/14/17 16:30Business NZ PMINOV New Zealand
Complete Economic Calendar
FDA Calendar
Event DateSymbolDrug NameEvent Name
03/02/18OTICOTIPRIO(sNDA)FDA decision on OTIPRIO for acute otitis externa
02/28/18AERIRhopressa (NDA)FDA decision on Rhopressa for the treatment of patients with open-angle glaucoma or ocular hypertension
02/23/18RHHBYEmicizumab (BLA)FDA decision on Emicizumab for haemophilia A with inhibitors
02/14/18AMAG, AMAGMakena subcutaneous auto-injector (sNDA)FDA decision on subcutaneous version of Makena to reduce the risk of preterm birth
01/24/18SGYPTRULANCE (sNDA)FDA decision on TRULANCE for the treatment of adults with irritable bowel syndrome with constipation
Complete FDA Calendar
>>
More